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Abstract
Background: The prevalence of food allergy (FA) among European school children 
is poorly defined. Estimates have commonly been based on parent-reported symp-
toms. We aimed to estimate the frequency of FA and sensitization against food al-
lergens in primary school children in eight European countries.
Methods: A follow-up assessment at age 6-10 years of a multicentre European birth co-
hort based was undertaken using an online parental questionnaire, clinical visits includ-
ing structured interviews and skin prick tests (SPT). Children with suspected FA were 
scheduled for double-blind, placebo-controlled oral food challenges (DBPCFC).
Results: A total of 6105 children participated in this school-age follow-up (57.8% 
of 10 563 recruited at birth). For 982 of 6069 children (16.2%), parents reported 
adverse reactions after food consumption in the online questionnaire. Of 2288 chil-
dren with parental face-to-face interviews and/or skin prick testing, 238 (10.4%) 
were eligible for a DBPCFC. Sixty-three foods were challenge-tested in 46 children. 
Twenty food challenges were positive in 17 children, including seven to hazelnut and 
three to peanut. Another seventy-one children were estimated to suffer FA among 
those who were eligible but refused DBPCFC. This yielded prevalence estimates for 
FA in school age between 1.4% (88 related to all 6105 participants of this follow-up) 
and 3.8% (88 related to 2289 with completed eligibility assessment).
Interpretation: In primary school children in eight European countries, the preva-
lence of FA was lower than expected even though parents of this cohort have be-
come especially aware of allergic reactions to food. There was moderate variation 
between centres hampering valid regional comparisons.
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birth cohort study, epidemiology, food allergy, IgE, prevalence
Correspondence
Linus Grabenhenrich, Department for 
Methodology and Research Infrastructure, 
Robert Koch-Institut, Berlin, Germany.
Email: GrabenhenrichL@rki.de
Kirsten Beyer, Department of Paediatric 
Pneumology, Immunology and Intensive 




European Commission, Grant/Award 
Number: FOOD-CT-2005-514000 and FP7-
KBBE-2012-6; grant agreement no. 312147
G R A P H I C A L  A B S T R A C T
Prospective observation of more than six thousand newborns estimated the frequency of food allergy, varying considerably by diagnostic 
approach. One in ten children had positive skin prick against common food allergens, but only few actually suffered from food allergy. This 
first multinational estimate of food allergy frequency challenges the widespread perception of an increase of allergic diseases.
Abbreviation: SPT, skin prick test
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1  | INTRODUC TION
Validly measuring the frequency of food allergy (FA) in the general 
population has been challenging, mainly due to the disease being 
very heterogeneous in terms of eliciting food allergens and clinical 
signs and symptoms. Furthermore, it is difficult to differentiate FA 
from other food hypersensitivities, such as food intolerances, in the 
general population. The different study settings and designs, case 
definitions, individual interpretations of the medical history includ-
ing observed appearances of FA and varying consumption habits 
have hampered sound comparisons of FA prevalence between re-
search projects, geographic regions and time trends.1-3 For example, 
studies aiming to estimate the prevalence of FA have applied dif-
ferent assessment techniques from questionnaires to double-blind 
placebo-controlled food challenges and have arrived at profoundly 
different estimates.4-9 A cross-sectional study in Germany targeting 
children from birth to 17 years reported a prevalence of FA of 61.6% 
based on self- and parent-reported information. Subsequently, sus-
pected cases of FA were examined clinically with food challenge 
tests, giving an estimated prevalence of confirmed FA of 2.2%.7 In a 
Danish sample including children and adults aged 4 to 22 years, the 
prevalence of FA was estimated at 1.0% and 0.3% based on open (ie 
nonblinded) and double-blind, placebo-controlled food challenges 
(DBPCFC), respectively.5 The prevalence of self-reported FA as-
sessed in primary school-age children was estimated at almost 6% 
in Turkey, and 6% to 12% in the United Kingdom. However, using 
DBPCFC led to prevalence estimates of 0.7% to 1.4% in these 
studies.4,8,10,11
The methodological challenges of assessing reactions to 
foods have prompted the development of standards for the diag-
nosis of FA, mainly in clinical settings.12 The birth cohort study 
from EuroPrevall (the prevalence, cost and basis of food allergy 
in eight European countries) agreed on a harmonized approach in 
all centres to confirm suspected FA using the diagnostic clinical 
gold-standard, that is DBPCFC, stringently in a large scale pop-
ulation-based study.13,14 Based on PRACTALL recommendations, 
the documentation and interpretation of oral food challenges has 
been developed further for the school-age follow-up of the birth 
cohort.12,15
In this manuscript, we report the range of frequencies of chal-
lenge-confirmed FA and sensitization against food allergens in 
primary school children from eight countries covering different 
European regions.
2  | METHODS
2.1 | Study design and setting
Starting in 2005, the EuroPrevall birth cohort set out to recruit 
newborns from nine European countries, to prospectively trace the 
onset of food allergy (FA) from birth to 2.5 years.14,16,17 Within the 
EU-funded iFAAM project (Integrated approaches to food allergen 
and allergy management), eight of the nine study centres (Iceland, 
United Kingdom, the Netherlands, Germany, Poland, Lithuania, 
Spain and Greece) took part in a single follow-up assessment at early 
school age (6 to 10 years, between 2014 and 2017). This follow-up 
aimed to reach all children initially recruited at birth (10 563) and 
document any previous parent-reported reactions to food as well as 
the current FA status. Ethical approval was obtained separately for 
all participating country, as listed above.
2.2 | Participants and sample definitions 
(denominators)
Recruitment details have previously been described.14 All recruited 
children of the EuroPrevall birth cohort (excluding the study cen-
tre in Italy) were re-invited for the current follow-up by invitation 
letters, electronic mail and/or telephone calls, for up to seven ap-
proaches, as required.
Parents were asked to complete an online questionnaire at home, 
at the same time providing consent to participate in the follow-up. A 
very limited number of questionnaires were completed in the study 
centre or via telephone interviews, for example in cases where par-
ents were unable or unwilling to access/complete the questionnaire 
by themselves. The questionnaire included items about previous re-
actions to food. Questionnaire data were reported for those with 
completed FA screening questions and the consumption history for 
a selection of commonly allergenic foods.
All children, irrespective of their FA history, were invited for a clin-
ical visit to the local study centre, including a face-to-face interview 
on previous and current food reactions, consumption habits and skin 
prick test (SPT) to a predefined panel of foods and aeroallergens, as 
well as foods reported to have previously caused reactions. The eligi-
bility for one or more oral food challenges was defined using an algo-
rithm based on interview data and SPT results (Figure 2). All forms and 
the diagnostic triage have been previously described.15 Study out-
comes based on interview data are reported for those who completed 
the clinical interview and have documented challenge eligibility.
2.3 | Data sources and variables (case definitions, 
numerators)
All outcome data reported in this manuscript were collected within 
the school-age follow-up of the birth cohort. Reports on previous or 
current reactions to food were derived from a single screening ques-
tion (Q1, Figure 2), further differentiated by physician's diagnosed 
FA, challenge-proven FA, symptoms by organ system, exposure-
symptom interval, age at first occurrence (all Q3), tolerance develop-
ment (Q4) and recent consumption (Q2, previous 3 months). Both 
the online questionnaire and the clinical face-to-face interview cov-
ered all these aspects.15
The current FA status (period/current prevalence of the po-
tential to react if exposed) was defined for a selected list of foods 
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(termed core foods): cow's milk, hen's egg, wheat, soy, peanut, hazel-
nut, white and oily fish and crustacean shell-fish. The consumption 
history for noncore foods was not assessed for children who never 
reported problems to a specific food.
A multi-level outcome assessment for the likelihood of current 
FA was derived from the questionnaire/interview data using a deci-
sion algorithm.15 This was further differentiated by details of recent 
symptoms and avoidance behaviour. Food challenge eligibility was 
derived from the likelihood of current FA, complemented by SPT re-
sults, that is individuals not currently consuming a suspected food 
with either previous symptoms following consumption of that food 
and/or a positive SPT (valid controls and largest wheal diameter ≥ 3 
mm; Figure 2) to that food.
2.4 | Assessment by DBPCFC tests
These were conducted based on previously published meth-
odology,12 and documented and interpreted as previously 
described.15 In brief, an escalating seven-dose protocol was 
followed to challenge children suspected to have FA. Children, 
families and medical staff were fully blinded to the order of the 
food/placebo given. Placebo days may have served as controls 
for more than one food, with each food/placebo tested on a 
separate day.
2.5 | Assessment of differential nonresponse
With the expectedly high attrition, we used several sources of 
information to assess differential nonresponse at school age, 
aiming to cover important characteristics in question to impact 
and/or predict allergy development. From the baseline assess-
ment of the birth cohort, we included the following: the child's 
sex, delivery mode, season of birth, use of antibiotics in the 
first week of life, older siblings, mother's current and smoking 
during pregnancy, cat and dog in household, parental allergies, 
child's eczema (parental report of eczema symptoms) and child's 
FA (previously proven by DBPCFC within the study). From the 
school-age follow-up, we included common atopy-associated 
diseases (asthma, allergic rhinitis and eczema), FA outcomes 
as described above, food-specific consumption habits and SPT 
results.
2.6 | Statistics and software
Study data were entered via a web interface, either by parents 
(questionnaire) or by study personnel (all other forms). The server 
architecture was specifically designed for data capturing in this 
project and to track completeness and congruency of the follow-
up assessment. Cleaning and statistical analyses were performed 
using SAS 9.4 (SAS Institute Inc, Cary, NC, USA). The initial sample 
size was set to assess the incidence of FA up to age 2 years, as 
described before.14 Outcome measures are reported by study 
centre, eliciting food and assessment method (questionnaire vs. 
interview). Raw frequencies were calculated as fractions of case 
definitions over corresponding samples, as described in the above 
subsections. Missing single items, besides those used to define 
sample membership, did not lead to the exclusion of the form or 
participant.
The potential for differential loss to follow-up was assessed 
comparing baseline characteristics and available outcome mea-
sures between groups of participants attending different numbers 
of follow-up assessments: (1) lost to follow-up, (2) questionnaire 
only, (3) eligible but not challenged, (4) eligible and challenged 
and (5) not eligible, using group-to-group comparisons with a chi-
squared statistic. Comparing the characteristics in three different 
group-to-group assessments, comparisons with a p-value below 
0.001 are highlighted. However, dichotomous test results were not 
used to guide the extrapolation strategy. As a manual weighting 
approach, the outcome frequencies in groups which were assessed 
were used as substitutes for groups where data for this outcome 
were not available. As an example, groups (3) and (4) were assumed 
to be quite similar, so the relative frequency of challenge-proven 
FA in those who completed the challenges (group (4)) was used 
to estimate the absolute number of potentially food allergic chil-
dren in those who were not challenged. With the expectedly large 
differences between point estimates introduced by different but 
all justifiable sets of assumptions, we report ranges of frequency 
estimates. Confidence intervals for proportion estimates were 
calculated assuming that errors follow the beta distribution, and 
using sample sizes of actually assessed children for the respective 
outcome.
2.6.1 | Role of the funding source
The birth cohort study was funded by the European Commission: 
(a) under the 6th Framework Programme (FOOD-CT-2005-514000) 
within the collaborative research initiative “EuroPrevall,” and (b) 
under the 7th Framework Programme (FP7-KBBE-2012-6; grant 
agreement no. 312 147) within the collaborative project “iFAAM.” 
Additional funds were received by the Icelandic birth cohort cen-
tre from Landspitali University Hospital Iceland Science Fund, and 
from GlaxoSmithKline Iceland; by the United Kingdom birth cohort 
centre from the UK Food Standards Agency; by the Polish birth 
cohort centre from the Ministry of Science and Higher education; 
by the Lithuanian birth cohort centre as unrestricted grants from 
Grida and MSD; and by the Dutch birth cohort centre as unrestricted 
grants from Nutricia Advanced Medical Nutrition Netherlands, 
AstraZeneca Netherlands, TEVA Netherlands, and GlaxoSmithKline 
Netherlands. None of the funding bodies had any influence on the 
study design the collection and analysis of data, interpretation of 
results, manuscript preparation or decision to submit the paper for 
publication.
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3  | RESULTS
3.1 | Participants
Parents completed the online questionnaire for 6069 out of the 
10 563 children recruited at birth (57.5%) at age 6-10 years. Of 
these 38.3% (n = 2322) of those came to the study centres for the 
face-to-face interview and physical examination including skin prick 
testing (SPT), which was carried out in 2188 participants (Figure 1). 
Questionnaire response differed by centre, ranging from 39.8% of 
those recruited in Southampton, UK, to 70.5% in Reykjavik, Iceland 
(Table 1). The mean age at follow-up was 8.3 years (standard devia-
tion 0.9). This report therefore covers a total observation period of 
50 733 person-years. The online questionnaire and the face-to-face 
interview allowed estimation of the frequency symptoms after food 
consumption until school age based on parental reports.
3.2 | Lifetime prevalence of symptoms after food 
consumption and physician's diagnosis of food allergy 
reported by the parents
Of the 6069 children who completed the online questionnaire, 
982 (16.2% [15.3-17.1]) had previous adverse reactions after food 
consumption. Physician's diagnosis of FA was less frequent when 
compared to symptoms alone for all countries, both based on par-
ent report. Cow's milk, hen's egg, peanut, hazelnut and wheat were 
the five most commonly implicated food items as causing symptoms 
(Table 1, Table S2). Numbers were similar for the 2322 children who 
came to the study centre for the face-to-face interview (Table S1). 
The majority (85.0%) of the reported reactions occurred < 2 hours 
after food consumption. Skin symptoms such as rash or pruritus 
(itching) and gastrointestinal reactions such as diarrhoea were the 
most frequently reported symptoms in all countries (Tables S3-S4).
F I G U R E  1   Number of children 
participating assessments and diagnostic 
steps and number of children lost to 
follow-up
EuroPrevall Sample
n = 12 049
iFAAM Baseline Sample
n = 10 563
Parcipated in school-age follow-up
n = 6105
n = 6069 complete quesonnaires
n = 2322 complete interviews







Not eligible (Group 5)
n = 2051
At least one challenge 
posive n = 17
All challenges
negave n = 29
Study centre Italy
n = 1486
Lost to follow-up (Group 1)
n = 4458
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3.3 | Food consumption and avoidance at school age
Based on 6069 online questionnaires, almost all children consumed 
foods containing cow's milk, hen's egg and wheat. Among the “core 
foods,” soy and crustacean shell-fish were consumed less often by 
school-aged children. The reason for not consuming a particular 
food was usually because that food was not part of the regular diet 
of the family, as assessed in the face-to-face interview. The foods 
most often avoided to prevent the development of FA were peanut 
and hazelnut (Table S5).
3.4 | Food allergy at school age—patient history
A total of 2289 children completed the eligibility assessment, based 
on reaction history (face-to-face interview) and complemented with 
allergic sensitization status based on skin prick tests (Figure 1). The 
decision tree to define current FA status was applied to all core foods 
separately, for example for peanut, for 57 of 2322 children's parents 
reported allergic symptoms after peanut consumption (Figure 2, 
Question 1 “yes”). If children either did not become tolerant as de-
scribed in the patient history (Question 4 “no/don't know”, n = 40) or 
became tolerant but did not consume the food without symptoms 
recently (previous 3 months, Question 2 “no”, n = 4), they were as-
sessed further as likely food allergic. The majority (2265) of chil-
dren had never had symptoms upon peanut consumption (Figure 2, 
Question 1 “no”), and if peanuts were consumed in the previous 
3 months without symptoms (Question 2 “yes”, n = 1863), the child 
was not eligible for a challenge (Type A), that is not peanut allergic on 
the basis of history alone. In children who did not consume peanuts 
in the last 3 months (n = 402), FA had to be considered possible as 
reactions upon exposure could not be ruled out (Figure 2, Table 2).
3.5 | Food allergy at school age—skin prick test 
(SPT)
A total of 223 of 2188 children (10.2% [9.0-11.5]) had a positive 
(≥3 mm) SPT to one or more “core foods.” Sensitization to peanut 
(5.6%) and hazelnut (5.2%) was most frequent (Figure 3).
3.6 | Food allergy at school age—DBPCFC
Of 2289 children for which eligibility was documented, 238 (10.4% 
[9.2-11.7]) were eligible for DBPCFC, either because they were likely 
to react based on the face-to-face interview (eg 42 children for cow's 
milk and 34 for hen's egg) or because they had not consumed the 
suspected food within the last 3 months and were sensitized to it 
(four children for cow's milk and six for hen's egg). The latter was 
common for hazelnut and peanut with 42 and 36 children, respec-
tively (Table 2). In total, we performed 63 DBPCFC in 46 children, 
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respectively). The parents of 192 participants refused the DBPCFC 
(Figure 1).
Twenty DBPCFC days where the incriminated food was given to 
17 children were rated positive (two with less pronounced symp-
toms on the placebo test day, and three without a placebo test day 
as the parents refused the placebo day after a clear positive reaction 
on the previous day where the incriminated food was given). Seven 
placebo tests were rated as positive out of all placebo challenges 
conducted in this study.
The 17 of 2097 (0.8% [0.5-1.3]) completely assessed children 
with a positive DBPCFC included seven children who reacted to 
hazelnut (0.3% [0.1-0.7]) and three to peanut (0.1% [0.0-0.4]). Only 
one child reacted to hen's egg (seven were challenged) and none to 
cow's milk (six were challenged; Table 2). Parents of all seven hazel-
nut-allergic children reported nasal symptoms in their children in the 
previous 12 months and two children had a physician's diagnosed 
allergic rhinitis. Among noncore foods, cashew (2), pine nut (2) and 
walnut (1) had positive DBPCFC tests (Table S6).
3.7 | Differential attrition
Frequency of FA within the whole cohort sample was extrapolated 
as not all participants completed all the necessary diagnostic steps 
to confirm or rule out current (prevalent) FA in school age. Children 
who did not take part in the school-age follow-up (group 1) came 
F I G U R E  2   Decision tree used to 
define current food allergy status, using 
peanut as an example (absolute numbers 



































































n = 40 n = 4 n = 402
n = 1863n = 13
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more often from less educated families but were quite similar in 
terms of allergic family predisposition, eczema in infancy and early 
childhood and other factors to those whose parents responded to 
the questionnaire but refused the clinical assessment of their child 
(group 2). Therefore, frequencies of FA in group 2 were used as sub-
stitutes for those not participating in the school-age follow-up (data 
and group labels in Table 3).
Children who came for a clinical visit, but were not eligible for a 
food challenge (group 5) had more parent-reported allergic rhinitis, 
eczema and more often an allergic family history than those only 
responding to the questionnaire (group 2). They were similar with 
regard to other potential indicators of FA such as sex and caesarean 
section (Table 3). Therefore, using FA frequencies from group 5 as 
substitutes for those not showing up for the clinical visit may yield 
only slightly upwards biased estimates.
Those children eligible, but whose parents refused the oral chal-
lenge testing (group 3), were quite similar to those eligible and suc-
cessfully challenged (group 4). The detailed comparison of these two 
groups in terms of food-specific sensitization, current symptoms (12 
m), previous FA diagnosis and specific food avoidance behaviour 
showed also very similar distributions. Specifically, the proportion of 
SPT positivity was similar in groups 3 and 4, with a considerable dif-
ference only in hen's egg sensitization (Table 4 and Figure S1). Thus, 
FA frequency in group 4 was used to estimate the number of poten-
tial food allergic children in group 3 (Table 3).
3.8 | Adjusted frequency of food allergy
A total of 238 children were eligible for an oral food challenge, of 
which 46 underwent a DBPCFC (group 4). In 192 children, parents 
refused this diagnostic step (group 3). In addition to the 17 positively 
challenged children, 71 children were estimated to have FA in the 
group eligible but refusing the challenge procedure under the as-
sumption of identical FA prevalence in those challenged and those 
eligible but not challenged (Tables 3 and 4), summing up to an esti-
mated number of 88 cases (rounding for the all-country estimator). 
These 88 cases would lead to an extrapolated prevalence estimate 
of 3.8% in the group of all 2289 children who completed the eligibil-
ity assessment. Under the assumption that all who participated in 
this follow-up but were not eligible for a food challenge had no FA, 
these estimated 88 cases would extrapolate to a school-age lower 
limit prevalence of current FA of 1.4% (of 6105 children; Figure 4). 
Furthermore, considering the high similarity between those who 
participated only in the questionnaire assessment and those who 
were lost to follow-up by school age, a lower limit prevalence of cur-
rent FA for the whole cohort would be 0.8% (88 of 10 563). Note 




In 17 of 2097 completely assessed school-age children from this 
European birth cohort study, food allergy (FA) to at least one aller-
gen source was confirmed, yielding an average raw prevalence of 
0.8% across all eight countries involved, as a lower limit estimate. 
Extrapolating to all children who completed the eligibility assess-
ment, we estimated an adjusted FA prevalence between 1.4% 
(extrapolated to all children with questionnaire data) and 3.8% (ex-
trapolated to those with completed eligibility assessment). Most 
of the positively challenged children reacted only mildly or moder-
ately, except for five children with severe signs or symptoms during 
DBPCFC. However, more severe reactions might have been ob-
served if those eligible but refusing to undergo the challenge were 
actually challenged. The most common allergens responsible for FA 
in school age and for allergic sensitization assessed by skin tests 
were hazelnut and peanut.
F I G U R E  3   Skin prick test (SPT) 
including allergens from the core food list 
in 2188 European children aged 6-10 y. 
A total of 223 (10.2%) children had a 
positive SPT. Error bars indicate 95% 
confidence intervals for the proportion of 
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The low absolute numbers per study centre hampered valid re-
gional comparisons.
4.2 | Comparison with other studies
Previous prevalence surveys were conducted only as single-centre 
studies and used different approaches hampering inter-country 
comparisons. As our measures were highly standardized, this is the 
first European multicentre study to report comparable estimates for 
the prevalence of FA in primary school age. Results of our study were 
in line with the few previous studies of children with comparable age 
from Turkey with a prevalence of 0.7% at 6-9 years,4 and 1.4% for 
6,8 and 1.3% for 10 year olds from the UK10 though these studies did 
not report adjusted estimates. However, the MAAS study in the UK 
reported peanut allergy prevalence alone of about 2% at age 8 years 
of age.11 The prevalence of FA in the HealthNuts study in Australia 
was estimated higher at 3.8% but in preschool children at 4 years of 
age; however, early life FAs against cow's milk and hen's egg are still 
more prevalent than among school-age children who have mostly 
become tolerant against these foods.18 Compared to the previous 
studies from Europe, we did not find an indication for an increase in 
the prevalence of FA in school age.
4.3 | Strengths and Limitations
Our birth cohort study that has been conducted in various European 
regions is the largest and first multinational population-based inves-
tigation of DBPCFC-confirmed FA in childhood worldwide. However, 
the generalizability of the initial sample to the whole (regional or 
whole-country) populations has not been formally assessed. Due 
to a stringent, standardized, clinically based methodology, it allows 
better comparisons of confirmed FA occurrence and influential 
factors in eight European countries than previous single-centre/-
country studies. The diagnostic work-up included several possible 
approaches to identify suspected FA, also capturing measures of 
disease severity and impact. It also focussed on the need to thor-
oughly adjust for the different types of nonresponse, particularly the 
refusal of a clinically indicated DBPCFC.19
The local consumption habits influence the likelihood that a dor-
mant potential to react to a certain allergen presents as an appar-
ent reaction. This limits the comparability, for example of different 
regions and parent-reported symptoms. We focussed the standard-
ized assessment of consumption and sensitization to a core list of 
major allergen sources and only for these foods the current preva-
lence estimates yield valid results. For all other foods, for which the 
consumption history and sensitization assessments were only avail-
able for children whose families reported problems ever, we can-
not present valid denominators for measures of disease frequency. 
We cannot exclude allergy to these foods in participants who may 
not be consuming them. Furthermore, groups of foods containing 
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in bakery products, would need to be differentiated in more detail. 
Including more and more foods in the consumption and sensitiza-
tion assessment would be likely to increase the number of identi-
fied yet unnoticed food allergies and thus increase the estimated 
frequencies.
The overall participation in the questionnaire assessment was 
comparable to other birth cohorts on allergy in Europe. There was 
considerable attrition in all stages of the assessment, form the 
questionnaire and clinical assessment to the final diagnostic step. 
We thoroughly assessed the potential for differential nonresponse 
and weighted after investigating a large set of background charac-
teristics, potentially giving a range of estimates that closer reflect 
the actual prevalence in the whole population, including those not 
assessed. Compared to other one-time surveys, this prevalence as-
sessment took place in a sample of children recruited at birth and 
followed until 30 months and later until school age for incident FA. 
This sample's families are likely to be more aware of this specific 
disease and also far more examined and assessed during infancy in 
search for food reactions.
A major weakness of the study was that a considerable number 
of families did not participate in the food challenges, which would 
have been necessary (based on the predefined eligibility criteria) to 
confirm or rule out FA. The willingness to undergo a time-consuming 
and stressful food challenge of at least two days is much lower with-
out the (felt) burden of the affected child and its family, usually the 
key trigger to consent to this procedure in regular care.
In one approach, we extrapolated the proportion of food allergic 
children of all challenged to those children who refused to undergo 
the procedure. There are many possible reasons for such refusal. 
Our prevalence estimates would be too low if severe reactions and 
previously challenge-proven food allergy were the main reason for 
the parents' hesitancy to allow food challenge. Thus, we reported a 
range of frequency estimates reflecting several probably extreme 
but justifiable sets of assumptions. Providing a single and robust 
point estimate supported by a reliable measure of precision would 
require a close to complete assessment of a population-based sam-
ple. As the uncertainty due to other factors than random error are 
likely to outweigh the potential variation due to chance/sampling, 
we explicitly refrained from calculating confidence intervals (which 
mainly address random error) for extrapolated frequencies.
4.4 | Conclusions
Depending on the strategy for weighting attrition, the occurrence 
of FA in European school children was estimated between 1.4% and 
3.8%, which was considerably lower than suspected from informa-
tion based on parental reports. The prevalence of food allergy of 
the children whose parents only completed the online question-
naire could only be estimated. Assuming they had the same prev-
alence of food allergy than those seen in the study centre likely 
overestimated the true frequency at 3.8%, whereas assuming they 
were all nonallergic would lead to a much  lower estimate (1.4%). 
The true prevalence is probably within this interval. The most com-
mon allergens responsible for FA and sensitization were peanut 
and hazelnut.
F I G U R E  4   Adjusted prevalence of 
challenge-proven food allergy, by follow-
up status. Lost to follow-up at school 
age (group 1) were 4458 out of 10 563 
subjects recruited at birth in 8 centres. 
Adjustment as follows, based on similarity 
of groups regarding baseline and follow-
up information as outlined in Table 3: (a) 
disease frequency of those challenged 
(group 4) as substitute for those eligible 
but refusing the challenge (group 3), with 
an additional estimated number of 71 
cases; (b) disease frequency of those not 
eligible (group 5) as substitute for those 
who only answered the questionnaire 
(no estimated cases added); Extrapolated 













































88 estimated cases/6,105 (1.4%)
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Eligible for cow's milk challenge (n = 47) 6 41
Of these…
Cow's milk SPT positive 17% 18%
Symptoms in previous 12 mo 83% 56%
Earlier physician's diagnosis 83% 39%
Current avoidance of cow's milk 50% 17%
Eligible for hen's egg challenge (n = 42) 7 35
Of these…
Hen's egg SPT positive 0% 57%
Symptoms in previous 12 mo 14% 20%
Earlier physician's diagnosis 43% 77%
Current avoidance of hen's egg 43% 40%
Eligible for peanut challenge (n = 66) 15 51
Of these…
Peanut SPT positive 85% 88%
Symptoms in previous 12 mo 0% 2%
Earlier physician's diagnosis 36% 39%
Current avoidance of peanut 64% 49%
Eligible for hazelnut challenge (n = 70) 16 54
Of these…
Hazelnut SPT positive 80% 73%
Symptoms in previous 12 mo 7% 7%
Earlier physician's diagnosis 33% 33%
Current avoidance of hazelnut 47% 46%
Eligible for crustacean challenge (n = 26) 7 19
Of these…
Crustacean SPT positive 71% 88%
Symptoms in previous 12 mo 0% 5%
Earlier physician's diagnosis 14% 21%
Current avoidance of crustaceans 43% 37%
TA B L E  4   Food-specific characteristics 
of challenge-eligible children, by challenge 
conduct. Only foods with more than 5 
conducted challenges
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